Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- For BP management in diabetes, debate continues on optimal definition, targets
-
- CREDENCE trial stopped early for favorable CKD findings with canagliflozin
- Transoral thyroidectomy may be comparable to traditional thyroid surgery
- Poor lifestyle confers CVD risk regardless of genetics
- Anxiety levels may predict fracture risk in postmenopausal women
- Delay in bottle-feeding may reduce early childhood obesity risk
- Diabetes intervention plus home visits boosts weight loss in mothers with overweight, obesity
- Diabetes raises risks for adverse outcomes following any surgery
- Early pregnancy iron deficiency may predict hypothyroxinemia in second, third trimester
-
- Fewer teens with overweight, obesity attempting to lose weight
- Healthy lifestyle lowers CVD risk in type 2 diabetes
- Higher-dose hydrocortisone may reduce symptoms in secondary adrenal insufficiency
- In childhood cancer survivors, GH therapy improves height without secondary tumor risk
- In hypothyroidism, formulation of levothyroxine therapy may influence adherence rates
- In transgender women, estrogen therapy may raise risk for VTE
- In women, type 1 diabetes associated with rheumatic disease, autoimmune conditions
- Levothyroxine dose in infancy may predict transient congenital hypothyroidism in children
-
- Maternal healthy lifestyle may lower obesity risk in offspring
- New Endocrine Society guideline stresses regular screenings for childhood cancer survivors
- ‘Normal-weight obesity’ linked to cardiometabolic risk in Chinese adults
- Oral macimorelin safe diagnostic test for adult GH deficiency
- Osteoporosis drug initiation rate continues to decline, raising fracture risk
- Statin use may lower fracture risk after stroke
- Thyroid function, antibody positivity associated with ovarian reserve in infertility
- Zoledronic acid may slow cancer treatment-induced bone loss in premenopausal women
-
- 6-month implantable CGM safe, accurate in teens, adults
- AACE/ACE algorithm: In type 2 diabetes, address multifactorial risk management
- Alirocumab plus statin cuts cardiac events in patients with diabetes, ACS
- Consumer technology poised to improve diabetes, CVD management
- Dual SGLT inhibitor boosts insulin efficacy in type 1 diabetes
- In diabetes with CVD, traditional risk factor modification remains top priority
- In emerging area of ‘diabetic lung disease,’ pioglitazone may play preventive role
- In type 2 diabetes, intensive therapy increases lifespan with no additional health care cost
-
- Insights from TEDDY study provide clues to islet autoimmunity in children
- Long-term testosterone therapy may prompt type 2 diabetes remission in men
- Maternal diabetes raises risk for autism spectrum diagnosis in offspring
- Most adults with diabetes, CVD do not meet secondary prevention targets
- Pramlintide addition improves on first-generation artificial pancreas systems
- Role for dairy in diabetes risk reduction debated
- VADT: After 15 years, a debate over glucose-lowering ‘legacy effect’
- Should patients with diabetes, microalbuminuria and normal BP be treated with renin-angiotensin system blockade?
-